Observational studyEuropean journal of medical research2025

Serum LACC1 level is a predictor of response to upadacitinib treatment in patients with rheumatoid arthritis: a prospective observational cohort study.

Zhou Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.